BIOHEAL THERAPEUTICS

BIOHEAL THERAPEUTICS Not FDA approved for sale in the USA.

Protevion Hydrogel is a flowable porcine amnion hydrogel wound dressing that conforms to any size or shape wound bed, providing a protective barrier and moisture management to support natural healing. Many wound care physicians get frustrated when applying amniotic tissue sheet products to their patients with chronic wounds when the sheet tears or folds over. Our BioHeal Hydrogel allows physicians

to easily apply our patented technology to support natural wound healing without wasting money or time.

https://trademarks.justia.com/878/33/bioheal-87833466.htmlXCell Biologix has received approval from the U.S. Patent and ...
10/18/2022

https://trademarks.justia.com/878/33/bioheal-87833466.html

XCell Biologix has received approval from the U.S. Patent and Trademark Office for the name BioHeal. BioHeal Hydrogel - XG100 is the companies first product candidate used for accelerating healing of chronic wounds and severe burns. BioHeal Hydrogel is made using XCell Biologix' proprietary & patented BioHeal Matrix Technology.

Biological preparations for the treatment of wounds

02/28/2019

XCELL is proud to be a Silver Sponsor for the Perinatal Stem Cell Congress.

https://www.eurekalert.org/pub_releases/2018-05/cp-cra050218.php
06/19/2018

https://www.eurekalert.org/pub_releases/2018-05/cp-cra050218.php

Scientists have developed a simple and robust approach for directly reprogramming mature skin cells into immature muscle cells, called induced myogenic progenitor cells (iMPCs). These cells propagated extensively and shared key molecular and functional properties with skeletal muscle stem cells. Whe...

Address

2500 Dallas Highway, Ste 202-1165
Marietta, GA
30064

Telephone

+19432220058

Website

Alerts

Be the first to know and let us send you an email when BIOHEAL THERAPEUTICS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to BIOHEAL THERAPEUTICS:

Shortcuts

Share

Category

About Us

XCELL BIOLOGIX™ is a global regenerative medicine company focused on innovative amnion derived technologies that could disrupt traditional painful and expensive treatment options for tissue regeneration and healing of chronic wounds and severe burns.

On November 15, 2017, XCELL BIOLOGIX™ signed an exclusive worldwide licensing agreement with the Wake Forest Institute for Regenerative Medicine (WFIRM), a research institute affiliated with Wake Forest School of Medicine, for development and commercialization rights for novel amnion derived technologies shown to accelerate wound closure and re-epithelialization for the protection, healing and repair of chronic wounds and severe burns. The company is rapidly building a portfolio of unique patented regenerative treatment product candidates to improve patients’ outcomes along with reducing pain and lowering costs.

Founded in 2015 by Bruce Anderson and Steve Anderson of Kennesaw, Georgia and Longboat Key, Florida respectively, the company has more than 70 years’ global experience developing, manufacturing, processing and commercializing more than 20 implantable human cardiovascular and orthopedic tissues as well as Class II and III medical devices. XCELL BIOLOGIX™ was formed in Florida and is headquartered in suburban Atlanta, Georgia.